iPSCs at the forefront of technology
Our expert team is committed to continually improve and provide the most advanced solutions to our customers. Here you can find our latest innovations, news and events that reflect the value of iPSCs in drug discovery and how Ncardia is leveraging that value, as well as trends and developments in the field.
Case Study: Development of a human iPSC-derived ALS model
Research highlights: Target identification to modulate neuroinflammation in ...
Case Study: Modelling Friedreich’s ataxia using patient-derived iPSCs
Adoption of complex disease modeling brings new optimism and hope to drug discovery
Whitepaper: Advancing drug discovery for neurodegenerative diseases
Research highlights: iPSCs for gene therapy development
Scientific poster: 3D iPSC-derived cardiac microtissues for drug discovery
Case Study: A model of Alzheimer’s disease
Expert Insights: Large-scale manufacture of iPSC models
Research highlights: Drug repurposing for Parkinson's disease, using iPSCs
Webinar: Human iPSC added value to the drug discovery pipeline
Webinar: iPSCs in gene therapy: Potent Solutions
Science, Innovation and Hope: How to advance drug discovery for neurodegenerative ...
Webinar: iPSC-based 3D microtissues and their applications in drug discovery
Webinar: The potential of iPSC-derived endothelial cells for efficacy and safety ...
Webinar: Developing novel human iPSC models for atrial fibrillation
Webinar: Assessment of drug-induced structural toxicity in human iPSC-derived ...
Webinar Series: Modeling Neurodegenerative Diseases
Webinar: Human iPSCs-derived neuronal and glial cells as relevant models for ...
Webinar: Robust human iPSC-derived neuronal and glial in vitro drug discovery assays
Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO
FDA Modernization Act of 2021: alternative testing platforms in drug discovery
Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer
Press release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC ...
Press release: Cell & gene therapy accelerator to de-risk early stage research
Optimization of the Ncyte Astrocyte Kit
Press release: improving the early detection, prevention and treatment of lung ...
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of ...
iCone Consortium hits milestone in large-scale production of iPSC-derived cortical ...
INSPIRE: A European safety pharmacology training network
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.